These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 16087332

  • 21. Potent and selective small molecule NS3 serine protease inhibitors of Hepatitis C virus with dichlorocyclopropylproline as P2 residue.
    Chen KX, Vibulbhan B, Yang W, Cheng KC, Liu R, Pichardo J, Butkiewicz N, Njoroge FG.
    Bioorg Med Chem; 2008 Feb 15; 16(4):1874-83. PubMed ID: 18032054
    [Abstract] [Full Text] [Related]

  • 22. Discovery of novel potent and selective dipeptide hepatitis C virus NS3/4A serine protease inhibitors.
    Raboisson P, Lin TI, Kock Hd, Vendeville S, Vreken WV, McGowan D, Tahri A, Hu L, Lenz O, Delouvroy F, Surleraux D, Wigerinck P, Nilsson M, Rosenquist S, Samuelsson B, Simmen K.
    Bioorg Med Chem Lett; 2008 Sep 15; 18(18):5095-100. PubMed ID: 18722116
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Hepatitis C virus NS3-4A serine protease inhibitors: SAR of new P1 derivatives of SCH 503034.
    Bogen S, Arasappan A, Pan W, Ruan S, Padilla A, Saksena AK, Girijavallabhan V, Njoroge FG.
    Bioorg Med Chem Lett; 2008 Jul 15; 18(14):4219-23. PubMed ID: 18547808
    [Abstract] [Full Text] [Related]

  • 25. Blunting the Swiss army knife of hepatitis C virus: inhibitors of NS3/4A protease.
    White PW, Llinas-Brunet M, Bös M.
    Prog Med Chem; 2006 Jul 15; 44():65-107. PubMed ID: 16697895
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The N-terminal region of NS3 serine proteinase of hepatitis C virus is important to maintain its enzymatic integrity.
    Mori A, Yuasa S, Yamada K, Nagami Y, Miyamura T.
    Biochem Biophys Res Commun; 1997 Feb 24; 231(3):738-42. PubMed ID: 9070884
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Discovery and structure-activity relationship of P1-P3 ketoamide derived macrocyclic inhibitors of hepatitis C virus NS3 protease.
    Venkatraman S, Velazquez F, Wu W, Blackman M, Chen KX, Bogen S, Nair L, Tong X, Chase R, Hart A, Agrawal S, Pichardo J, Prongay A, Cheng KC, Girijavallabhan V, Piwinski J, Shih NY, Njoroge FG.
    J Med Chem; 2009 Jan 22; 52(2):336-46. PubMed ID: 19102654
    [Abstract] [Full Text] [Related]

  • 36. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
    Thibeault D, Massariol MJ, Zhao S, Welchner E, Goudreau N, Gingras R, Llinàs-Brunet M, White PW.
    Biochemistry; 2009 Feb 03; 48(4):744-53. PubMed ID: 19119853
    [Abstract] [Full Text] [Related]

  • 37. Hepatitis C virus NS3 protease inhibitors comprising a novel aromatic P1 moiety.
    Rönn R, Lampa A, Peterson SD, Gossas T, Akerblom E, Danielson UH, Karlén A, Sandström A.
    Bioorg Med Chem; 2008 Mar 15; 16(6):2955-67. PubMed ID: 18194867
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prediction of binding for a kind of non-peptic HCV NS3 serine protease inhibitors from plants by molecular docking and MM-PBSA method.
    Li X, Zhang W, Qiao X, Xu X.
    Bioorg Med Chem; 2007 Jan 01; 15(1):220-6. PubMed ID: 17064917
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.